DVA vs MGNX · P/E 14, rev $6.97B vs rev $39.6M
DaVita HealthCare Partners Inc (DVA) versus MacroGenics Inc (MGNX) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
MacroGenics Inc (MGNX) is a biotechnology company listed on NASDAQ.
Latest reported DVA revenue for 2026-06-30 was $6.97B. Net income was $462.9M. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Latest reported MGNX revenue for 2026-06-30 was $39.6M. Net income was -$17.3M. Revenue was up 90.4% from 2026-03-31 to 2026-06-30. MGNX currently screens at market cap $246.6M.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. MGNX currently screens at market cap $246.6M.
Not investment advice. Open the DVA and MGNX stock pages for the full models.
Not investment advice.